194 studies on Oxidative stress mechanism curated from PubMed, ClinicalTrials.gov, and EuropePMC. Updated daily.
This research highlights GHRP-6 as a promising therapeutic agent to protect against the severe organ damage caused by doxorubicin chemotherapy. By activating intrinsic prosurvival mechanisms, GHRP-6 could potentially …
This research highlights Danshen-Chuanxiong-Honghua (DCH) as a promising multi-target therapeutic agent for traumatic brain injury, offering both anti-inflammatory and neuroprotective benefits. The specific identifica…
This groundbreaking study provides compelling evidence that the GHRP-6 hydrogel represents a highly promising and innovative therapeutic strategy for Acute Kidney Injury. Its unique ability to provide sustained local …
This research provides a crucial insight into the complex interplay between oxidative stress and atherosclerosis, suggesting that GHRP-2's potent antioxidant effects might not be sufficient to halt the multifaceted pr…
This study provides compelling evidence that targeting the GHRH/GH axis with an antagonist can significantly impact multiple facets of aging, including longevity, oxidative stress, and telomerase activity. The observe…
This research provides compelling evidence that activating GHRH signaling can effectively counteract the neurodegenerative processes triggered by intermittent hypoxia. This suggests that GHRH agonists could represent …
This study provides compelling evidence that GHRH analogs possess significant anti-inflammatory, antioxidant, and beneficial behavioral properties, extending their therapeutic potential beyond endocrine regulation. Th…
This research highlights a significant new therapeutic potential for GHRH antagonists, particularly MIA-602, in conditions involving blood-brain barrier dysfunction. Given their ability to protect brain microvascular …
This study highlights MR-409 as a promising therapeutic candidate for preventing beta-cell destruction, a critical step in managing Type 1 Diabetes and potentially other forms of diabetes where beta-cell loss is a fac…
These findings fundamentally advance our understanding of how antimicrobial peptides interact, highlighting that peptide aggregation is a critical determinant of AMP structure-function relationships. This mechanistic …
This research is crucial as it highlights the potential of ghrelin and synthetic growth hormone secretagogues as novel therapeutic agents for treating acute ischemic heart disease, such as myocardial infarction (heart…
This study provides compelling evidence that Epitalon possesses significant geroprotective and anti-carcinogenic properties in an animal model. The observed increases in lifespan and reductions in tumor incidence, cou…
This compelling research provides strong evidence that targeted peptide intervention, specifically with Epitalon, can effectively reverse or significantly mitigate age-related decline in pineal gland function. The res…
These findings strongly support the role of pineal geroprotective peptides, specifically Epitalon and Vilon, as potent antioxidants capable of mitigating age-related oxidative stress. By enhancing endogenous antioxida…
These findings highlight the significant role of the pineal gland and environmental light in modulating age-related muscle decline. The observed improvements in exercise capacity and biochemical markers suggest that p…
This research highlights the critical, yet often overlooked, role of environmental light conditions in influencing age-related changes in the body's antioxidant defenses, particularly in the liver. Understanding how f…
This study highlights the therapeutic potential of bioactive tetrapeptides like Epithalon and Cortagen in combating oxidative stress, a fundamental driver of aging and numerous pathological conditions. Given that oxid…
The findings highlight Pinealon as a highly promising neuroprotective agent with a multifaceted mechanism of action. Its ability to bolster the body's intrinsic antioxidant defenses and potentially modulate N-methyl-D…
This research uncovers novel mechanisms by which short regulatory peptides exert their protective effects, moving beyond simple direct antioxidant activity. The findings suggest these peptides could play a crucial rol…
This research highlights the potential of organospecific peptides like T-31, T-35, and epitalon as promising therapeutic agents for rhabdomyolysis-induced acute kidney injury. By simultaneously targeting multiple unde…
This research provides compelling evidence that Epitalon can effectively delay the aging process of oocytes in vitro by modulating crucial cellular pathways, specifically by reducing ROS levels and enhancing mitochond…
Epitalon's ability to modulate key aging pathways, including telomerase activation and antioxidant defense, positions it as a highly promising geroprotective agent. Its pleiotropic effects suggest potential applicatio…
This research provides compelling evidence for Epitalon's therapeutic potential in combating the cellular damage and impaired healing associated with diabetic retinopathy. By demonstrating its ability to enhance wound…
These findings strongly suggest that Mexidol and Semax, particularly in combination, could be highly effective neuroprotective and cognitive-enhancing agents for conditions involving hypoxic brain injury. Their abilit…
This research provides compelling evidence for the therapeutic potential of Semax as a neuroprotective agent against metal-induced toxicity, a critical factor in the pathogenesis of several debilitating neurodegenerat…
This study provides compelling evidence for the hepatoprotective potential of Semax in mitigating stress-induced liver damage and dysfunction. The peptide's ability to normalize liver enzyme activities and protein syn…
This research highlights that while Semax possesses general antioxidant properties, its effects on liver enzyme markers under stress are highly nuanced and dose- and context-dependent. The finding that higher doses ca…
This study provides compelling evidence for the neuroprotective properties of Semax against heavy metal-induced cognitive impairment. Given the widespread environmental exposure to heavy metals and their significant i…
This novel iPSC-based platform offers a powerful, human-relevant tool for accelerating neuroprotective drug discovery, potentially reducing the reliance on less predictive animal models and improving the translatabili…
This research highlights PGC-1α activation as a promising therapeutic strategy for mitigating brain damage following ischemic stroke. By enhancing mitochondrial function and reducing oxidative stress, PGC-1α activator…
This study provides critical molecular evidence supporting ACTH's neuroprotective role by elucidating its impact on the brain's protein landscape. The upregulation of neurotrophic factors like BDNF and downregulation …
This research highlights Semax's potential as a neuroprotective agent against key aspects of Alzheimer's disease (AD) pathology. By targeting metal-induced oxidative stress, Semax offers a novel therapeutic strategy t…
This study provides compelling evidence that Selank possesses significant hepatoprotective and antioxidant properties, effectively shielding the liver from the damaging effects of both acute and chronic restraint stre…
This study highlights MOTS-c as a crucial mediator of the cardioprotective effects of aerobic exercise in diabetic myocardial injury, primarily through enhancing antioxidant defense. The findings suggest that targetin…
This study provides compelling evidence that MOTS-c peptide could be a novel and effective therapeutic agent for diabetic cardiomyopathy. Its ability to improve cardiac function, reduce fibrosis, and mitigate oxidativ…
This research highlights MOTS-c as a promising therapeutic agent for combating muscle wasting and associated fat infiltration caused by immobilization. The ability of MOTS-c to simultaneously preserve muscle mass and …
This research provides compelling evidence that mitochondria-derived peptides represent a novel and promising therapeutic strategy for treating painful diabetic neuropathy. By directly targeting mitochondrial dysfunct…
This groundbreaking research highlights MOTS-c as a highly promising novel therapeutic agent for the prevention and treatment of radiation pneumonitis. Its ability to simultaneously modulate inflammation, reduce oxida…
This study provides a robust mechanistic framework for understanding how MOTS-c protects the brain after traumatic injury, highlighting its role in enhancing mitochondrial function and reducing inflammation and oxidat…
This research is significant as it identifies Humanin and MOTS-c as potential protective agents against chemotherapy-induced reproductive damage. Given the devastating impact of male infertility on cancer survivors, f…
This research highlights Pyrroloquinoline Quinone (PQQ) as a promising therapeutic agent for mitigating radiation-induced lung injury (RILI), a debilitating side effect of cancer radiotherapy. By demonstrating PQQ's a…
These findings are crucial as they identify multiple novel biomarkers that could potentially aid in the early detection and risk stratification of preeclampsia. Understanding the altered expression of VPO1, humanin, M…
The most significant finding was that MOTS-c administration achieved comparable or superior protective effects to remote ischemic preconditioning in mitigating lung ischemia-reperfusion injury, reducing tissue damage …
This research highlights MOTS-c as a promising novel therapeutic candidate for age-related macular degeneration (AMD), addressing the critical need for treatments that target the underlying mitochondrial dysfunction. …
This review underscores the immense therapeutic potential of mitochondria-derived peptides as a novel class of agents for treating cardiovascular diseases. By directly targeting mitochondrial dysfunction, MDPs offer a…
This study provides compelling evidence that MOTS-c offers a robust protective effect against lung ischemia-reperfusion injury through a novel MYH9-dependent mechanism. The identification of MYH9 as a key mediator lin…
This research highlights MOTS-c as a promising novel therapeutic agent for allergic asthma, offering a unique approach by targeting a fundamental aspect of the disease: airway barrier dysfunction and epithelial apopto…